News & Updates

Postoperative neutropaenia tied to early CRBSI in children with leukaemia
Postoperative neutropaenia tied to early CRBSI in children with leukaemia
05 Jan 2023 byStephen Padilla

Paediatric patients with acute myeloid leukaemia and other leukaemias (AML/OLs), especially those with persistent neutropaenia during the first 30 postoperative days, are at increased risk of early catheter-related bloodstream infections (CRBSIs), according to a Singapore study.

Postoperative neutropaenia tied to early CRBSI in children with leukaemia
05 Jan 2023
SG kids prone to multisystem inflammatory syndrome amid high COVID-19 transmission
SG kids prone to multisystem inflammatory syndrome amid high COVID-19 transmission
04 Jan 2023
Edoxaban prevents thromboembolism in children with cardiac disease
Edoxaban prevents thromboembolism in children with cardiac disease
04 Jan 2023

Edoxaban may be used as an alternative treatment for thromboembolism (TE) prevention in children with cardiac disease showing low rates of clinically relevant bleeding and TE, suggests a study. Some of its advantages include once-daily dosing and infrequent monitoring requirement.

Edoxaban prevents thromboembolism in children with cardiac disease
04 Jan 2023
Parkinson’s, T2D drug affords cardioprotection in youth with T1D
Parkinson’s, T2D drug affords cardioprotection in youth with T1D
31 Dec 2022 byJairia Dela Cruz

Bromocriptine quick release, a medication used for Parkinson’s disease and type 2 diabetes (T2D), appears to confer cardiovascular benefits such as lower blood pressure (BP) and reduced aortic stiffness in teenagers with type 1 diabetes (T1D), according to data from the BCQR-T1D study.

Parkinson’s, T2D drug affords cardioprotection in youth with T1D
31 Dec 2022